Drugs / CD4+CD25+CD127lowFoxP3+ T regulatory cells
last change Nov 2014 re-read 2 minutes ago

CD4+CD25+CD127lowFoxP3+ T regulatory cells

Cell therapy

Developed for
end stage renal failure · kidney failure
Investigated by
Pirogov Russian National Research Medical University · Russian Academy of Medical Sciences

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01446484 Oct 2011 → Nov 2014 end stage renal failure, kidney failure Pirogov Russian National Research Medical University Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD4+CD25+CD127lowFoxP3+ T regulatory cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT01446484
Modality Cell therapy Cell therapyNCT01446484
Route Subcutaneous subcutaneous injection” NCT01446484